SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

C154 - Autism Spectrum Disorders What We Know and Where We Are Going

Event Time: Wednesday April 26, 2017 7:00 am to 9:00 am
Topic(s): Child Neurology and Developmental Neurology
Director(s): Frances Jensen MD, FAAN
Description: Faculty will emphasize the clinical application of the DSM-5 for the diagnosis of ASD, identification of genetic disorders with ASD and how to test for these, the utility of diagnosing epilepsy in this population, and what AEDS are useful. In addition we review recent advances in translational research in to autism disorders that are likely to provide the foundation for future biomarker and therapeutic advances.
Completion Message: Participants should be able to understand how to apply the DSM-5 criteria in diagnosing ASD, recognize some specific genetic disorders associated with ASD and how to test for these, and know which epilepsy syndrome are associated with ASD and which AEDs are useful and tolerated in patients with ASD.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge

Program Speakers - Tentative

Start/End Time Title Faculty
7:00 AM - 7:15 AM Introduction Frances Jensen MD, FAAN 
7:15 AM - 7:45 AM Diagnosis of Autism: Impact of DSM5 Alyssa Rosen MD 
7:45 AM - 7:50 AM Questions and Answers Faculty 
7:50 AM - 8:20 AM Overview of Medical and Genetic Workup and Treatment Options in Individuals with ASD Sarah Spence MD, PhD 
8:20 AM - 8:25 AM Questions and Answers Faculty 
8:25 AM - 8:55 AM Recent Research Advances in the Neurobiology of Autism Mustafa Sahin MD, PhD 
8:50 AM - 8:55 AM Questions and Answers Faculty 


Speaker Disclosure
Frances E. Jensen, MD, FAAN no. no. no. no. Eisai for investigator initiated research.

Alyssa Rachel Rosen, MD Dr. Rosen has nothing to disclose.

Mustafa Sahin, MD, PhD Consultant - Roche Member of Scientific Advisory Board- Sage Therapeutics. Associate Editor- Pediatric Neurology. Dr Sahin received financial support for research activities for Novartis, Pfizer, and LAM Therapeutics..

Sarah J. Spence, MD,PhD Dr. Spence has nothing to disclose.

Register Now

Related Courses

Saturday April 21, 2018

9:30 AM-11:30 AM
C11 Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN
1:30 PM-3:30 PM
C18 Pediatric Neuro-ophthalmology Update Christopher Glisson DO
C21 Stroke in Young Adults and Women Aneesh Singhal MD, FAAN

Sunday April 22, 2018

7:00 AM-9:00 AM
C27 Autism Spectrum Disorders What We Know and Where We Are Going Rujuta Bhatt MD
9:15 AM-12:00 PM
PL2 Presidential Plenary Session
3:30 PM-5:30 PM
N1 Neuroscience in the Clinic: Autism Myth Busters Shafali Jeste MD,
Sarah Spence MD,PhD

Monday April 23, 2018

7:00 AM-9:00 AM
C62 Child Neurology I: Pediatric Stroke, MS/Autoimmune Marc Patterson MD, FAAN, FRACP
1:00 PM-3:00 PM
C70 Child Neurology II: Epilepsy and Neuromuscular Marc Patterson MD, FAAN, FRACP
3:30 PM-5:30 PM
C85 Child Neurology III: Headache, TBI/Post-concussion Marc Patterson MD, FAAN, FRACP

Tuesday April 24, 2018

1:00 PM-3:00 PM
C108 Neurologic Complications in Adults with Down Syndrome Andrea Gropman MD
3:30 PM-5:30 PM
C122 Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN

Wednesday April 25, 2018

7:00 AM-9:00 AM
C140 Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN


Forgot Password?